GlycoMimetics Inc. (GLYC)
0.25
-0.01 (-3.36%)
At close: Mar 04, 2025, 2:14 PM
GlycoMimetics Cash Flow Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Net Income | -37.88B | -36.9M | -46.69M | -63.43M | -51.03M | -57.89M | -48.27M | -33.28M | -31.81M | -12.77M | -11.12M | -10.61M | 3.66M | -6.11M |
Depreciation & Amortization | 35.17M | 153.3K | 207.15K | 264.6K | 270.75K | 279.23K | 275.12K | 263.54K | 190.54K | 191.48K | 158.71K | 133.05K | 99.92K | 83.86K |
Stock-Based Compensation | 4.7B | 3.56M | 3.86M | 6.09M | 6.9M | 6.22M | 4.59M | 3.76M | 2.96M | 2.32M | 1.64M | 425.69K | 415.21K | 376.24K |
Other Working Capital | 1.7M | -2.46M | -3.52M | -1.18M | 3.28M | 21.3K | 63.63K | -1.57M | -2.08M | 146.63K | 5.32M | -5.87M | -14.87M | 19.42M |
Other Non-Cash Items | 2.05B | 864.87K | 828.51K | 749.04K | 680.85K | 620.07K | 168.00 | 3.23M | 2.96M | 2.32M | 1.42K | 425.69K | 415.21K | n/a |
Deferred Income Tax | n/a | n/a | n/a | 2.17K | n/a | n/a | n/a | n/a | -2.96M | -2.32M | n/a | -425.69K | -415.21K | n/a |
Change in Working Capital | 1.16M | -2.56M | -4.66M | -1.17M | 3.93M | -1.21M | 80.11K | -511.64K | -1.08M | 2M | 5.04M | -5.49M | -14.64M | 19.51M |
Operating Cash Flow | -31.1B | -34.88M | -46.46M | -57.49M | -39.24M | -51.98M | -43.33M | -29.77M | -29.73M | -8.24M | -4.28M | -15.54M | -10.47M | 13.85M |
Capital Expenditures | -9.97K | -21.39K | -84.19K | -14.94K | -68.51K | -144.93K | -125.62K | -294.11K | -704.2K | -268.59K | -212.6K | -82.09K | -316.18K | -182.44K |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 30M | n/a | n/a | n/a | n/a | n/a | -126K | n/a | n/a | n/a | n/a | n/a | -10K | -57.7K |
Investing Cash Flow | 20.03M | -21.39K | -84.19K | -14.94K | -68.51K | -144.93K | -125.62K | -294.11K | -704.2K | -268.59K | -212.6K | -82.09K | -326.18K | -240.14K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.17K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.4M | 116.5K | n/a | 25.03K | 319.3K | 412.91K | 1.02M | 373.38K | 72.59K | 114.12K | 134.29K | n/a | 237.00 | n/a |
Financial Cash Flow | 5.4M | 28.82M | 4.16M | 10.72M | 18.14M | 412.91K | 129.45M | 113.95M | 23.67M | 114.12K | 57.38M | 558.93K | 237.00 | -24.16K |
Net Cash Flow | -31.07B | -6.08M | -42.38M | -46.78M | -21.17M | -51.72M | 85.99M | 83.88M | -6.76M | -8.4M | 52.89M | -15.06M | -10.8M | 13.59M |
Free Cash Flow | -31.11B | -34.9M | -46.54M | -57.5M | -39.31M | -52.13M | -43.46M | -30.06M | -30.44M | -8.51M | -4.49M | -15.62M | -10.79M | 13.67M |